News & Updates
Filter by Specialty:
Low-carb diets may improve renal, CV risk factors in T2D patients
29 Sep 2021
byAudrey Abella
In individuals with type 2 diabetes (T2D), low-carbohydrate diets (LCDs) may improve renal and cardiovascular (CV) risk factors, suggests a review from the UK.
Low-carb diets may improve renal, CV risk factors in T2D patients
29 Sep 2021
DPP-4–to–SGLT2 inhibitor switch confers multiple benefits for patients with diabetes, hypertension
28 Sep 2021
byJairia Dela Cruz
In the treatment of patients with type 2 diabetes mellitus and hypertension, switching from a dipeptidyl peptidase-4 (DPP-4) inhibitor to the sodium-glucose cotransporter-2 (SGLT2) inhibitor luseogliflozin appears to have favourable effects on blood pressure (BP), circadian rhythm, and night-time systolic BP (SBP) and pulse rate (PR), according to data from the open-label LUNA trial.
DPP-4–to–SGLT2 inhibitor switch confers multiple benefits for patients with diabetes, hypertension
28 Sep 2021
Side effects limit long-term therapy for primary aldosteronism
28 Sep 2021
byTristan Manalac
Long-term medical therapy in patients with primary aldosteronism (PA) is held back by dose-dependent side effects, according to a recent Singapore study.
